Lead sponsor
University of Washington
3 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
3
Trials led
2
Active
212
Total enrollment
16
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2
1
Phase 4
2
Trials by status
Recruiting
2
Completed
1
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 DiabetesHbA1c 7-10%Ph 4Recruiting50